57
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Association of incidental emphysema with annual lung function decline and future development of airflow limitation

, , , &
Pages 161-166 | Published online: 29 Jan 2016

References

  • JanssensJPPacheJCNicodLPPhysiological changes in respiratory function associated with ageingEur Respir J19991319720510836348
  • RoisinRRGlobal Strategy for the Diagnosis, Management and Prevention of COPD Updated 20112015 Available from: http://www.goldcopd.orgAccessed November 26, 2015
  • ItoKBarnesPJCOPD as a disease of accelerated lung agingChest200913517318019136405
  • HoggJCPathophysiology of airflow limitation in chronic obstructive pulmonary diseaseLancet200436470972115325838
  • ZuluetaJJWisniveskyJPHenschkeCIEmphysema scores predict death from COPD and lung cancerChest20121411216122322016483
  • JohannessenASkorgeTDBottaiMMortality by level of emphysema and airway wall thicknessAm J Respir Crit Care Med201318760260823328525
  • StolkJPutterHBakkerEMProgression parameters for emphysema: a clinical investigationRespir Med20071011924193017644366
  • NishimuraMMakitaHNagaiKHokkaido COPD Cohort Study InvestigatorsAnnual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012185445222016444
  • YuanRHoggJCParéPDPrediction of the rate of decline in FEV(1) in smokers using quantitative computed tomographyThorax20096494494919734130
  • Remy-JardinMEdmeJLBoulenguezCLongitudinal follow-up study of smoker’s lung with thin-section CT in correlation with pulmonary function testsRadiology200222226127011756735
  • HoeseinMFAde HoopBZanenPCT quantified emphysema in male heavy smokers: association with lung function declineThorax20116678278721474499
  • MascalchiMDiciottiSSverzellatiNLow agreement of visual rating for detailed quantification of pulmonary emphysema in whole-lung CTActa Radiol201253536022114019
  • GouldGAMacNeeWMcLeanACT measurements of lung density in life can quantitate distal airspace enlargement–an essential defining feature of human emphysemaAm Rev Respir Dis19881373803923341629
  • American Thoracic SocietySingle-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique – 1995 updateAm J Respir Crit Care Med1995152218521988520796
  • MorrisJFKoskiAJohnsonLCSpirometric standards for healthy nonsmoking adultsAm Rev Respir Dis197110357675540840
  • LeeCHLeeJYJangEJNew predictive equations for spirometric reference values and comparison with Morris equation in a Korean populationRespirology20081336537118399858
  • GevenoisPADe VuystPde MaertelaerVComparison of computed density and microscopic morphometry in pulmonary emphysemaAm J Respir Crit Care Med19961541871928680679
  • WangZGuSLeaderJKOptimal threshold in CT quantification of emphysemaEur Radiol20132397598423111815
  • HershCPMakeBJLymchDANone-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitusBMC Pulm Med20141416425341556
  • GieradaDSPilgramTKWhitingBRComparison of standard- and low-radiation-dose CT for quantification of emphysemaAJR Am J Roentgenol20071881424717179344
  • WangRSuiXSchoepfUJUltralow-radiation-dose chest CT: accuracy for lung densitometry and emphysema detectionAJR Am J Roentgenol2015204474374925794063
  • HagueCJKrowchukNAlhassanDQualitative and quantitative assessment of smoking-related lung disease: effect of iterative reconstruction on low-dose computed tomographic examinationsJ Thorac Imaging201429635035625314025
  • MetsOMSchmidtMBuckensCFDiagnosis of chronic obstructive pulmonary disease in lung cancer screening computed tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickeningRespir Res2013145923711184
  • CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med200817833233818511702
  • DecramerMCelliBKestenSUPLIFT InvestigatorsEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet20093741171117819716598
  • TashkinDPCelliBSennSUPLIFT Study InvestigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
  • PauwelsRALöfdahlCGLaitinenLALong-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European respiratory society study on chronic obstructive pulmonary diseaseN Engl J Med19993401948195310379018
  • Lung Health Study Research GroupEffect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary diseaseN Engl J Med20003431902190911136260
  • BurgePSCalverleyPMJonesPWRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ20003201297130310807619
  • FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J1977116451648871704
  • AhnHSKimHJWelchHGKorea’s thyroid-cancer “epidemic” – screening and overdiagnosisN Engl J Med2014371191765176725372084
  • VestboJEdwardsLDScanlonPDECLIPSE InvestigatorsChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med20113651184119221991892
  • Mohamed HoeseinFAvan RikxoortEvan GinnekenBComputed tomography-quantified emphysema distribution is associated with lung function declineEur Respir J20124084485022323577
  • MeadJTurnerJMMacklemPTSignificance of the relationship between lung recoil and maximum expiratory flowJ Appl Physiol196722951086017658
  • SalviSSBarnesPJChronic obstructive pulmonary disease in nonsmokersLancet200937473374319716966
  • ChenCZOuCYWangWLUsing post-bronchodilator FEV1 is better than pre-bronchodilator FEV1 in evaluation of COPD severityCOPD2012927628022360379